Cargando…

Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment

BACKGROUND: Through high-throughput next-generation sequencing of promoters of solute carrier and ATP-binding cassette genes, which encode drug transporters, we aimed to identify SNPs associated with the response to imatinib administered for first-line treatment of patients with chronic myeloid leuk...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jaruskova, Monika, Curik, Nikola, Hercog, Rajna, Polivkova, Vaclava, Motlova, Eliska, Benes, Vladimir, Klamova, Hana, Pecherkova, Pavla, Belohlavkova, Petra, Vrbacky, Filip, Machova Polakova, Katerina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395939/ https://www.ncbi.nlm.nih.gov/pubmed/28420426 http://dx.doi.org/10.1186/s13046-017-0523-3

Ejemplares similares

Interferon-α Revisited: Individualized Treatment Management Eased the Selective Pressure of Tyrosine Kinase Inhibitors on BCR-ABL1 Mutations Resulting in a Molecular Response in High-Risk CML Patients
por: Polivkova, Vaclava, et al.
Publicado: (2016)

S152: COMBINATORY THERAPY OF ASCIMINIB AND PONATINIB WAS EFFECTIVE IN THE TREATMENT OF BLAST PHASE CML CDX MODEL
por: Čuřík, Nikola, et al.
Publicado: (2023)

BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia
por: Srutova, Klara, et al.
Publicado: (2018)

P397: IKZF1 ALTERATIONS HAVE A NEGATIVE IMPACT ON EARLY MOLECULAR RESPONSE AND SURVIVAL OF ADULT PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH GMALL 07/2003 PROTOCOL IN CZECHIA
por: Polivkova, Vaclava, et al.
Publicado: (2023)

Characterization of 46 patient-specific BCR-ABL1 fusions and detection of SNPs upstream and downstream the breakpoints in chronic myeloid leukemia using next generation sequencing
por: Linhartova, Jana, et al.
Publicado: (2015)

Metformin Pharmacogenetics: Effects of SLC22A1, SLC22A2, and SLC22A3 Polymorphisms on Glycemic Control and HbA1c Levels
por: AL-Eitan, Laith N., et al.
Publicado: (2019)

Association of SLC22A1, SLC22A2, SLC47A1, and SLC47A2 Polymorphisms with Metformin Efficacy in Type 2 Diabetic Patients
por: Chen, Peixian, et al.
Publicado: (2022)

Trospium Chloride Transport by Mouse Drug Carriers of the Slc22 and Slc47 Families
por: Gorecki, Matthias, et al.
Publicado: (2020)

Interaction of Natural Dietary and Herbal Anionic Compounds and Flavonoids with Human Organic Anion Transporters 1 (SLC22A6), 3 (SLC22A8), and 4 (SLC22A11)
por: Wang, Li, et al.
Publicado: (2013)

Evaluation of the Influence of Genetic Variants of SLC2A9 (GLUT9) and SLC22A12 (URAT1) on the Development of Hyperuricemia and Gout
por: Pavelcova, Katerina, et al.
Publicado: (2020)

Somatic Mutations in Oncogenes Are in Chronic Myeloid Leukemia Acquired De Novo via Deregulated Base-Excision Repair and Alternative Non-Homologous End Joining
por: Curik, Nikola, et al.
Publicado: (2021)

Evidence for the association of the SLC22A4 and SLC22A5 genes with Type 1 Diabetes: a case control study
por: Santiago, Jose Luis, et al.
Publicado: (2006)

Uptake Transporters of the SLC21, SLC22A, and SLC15A Families in Anticancer Therapy—Modulators of Cellular Entry or Pharmacokinetics?
por: Brecht, Karin, et al.
Publicado: (2020)

SLC22A1-ABCB1 Haplotype Profiles Predict Imatinib Pharmacokinetics in Asian Patients with Chronic Myeloid Leukemia
por: Singh, Onkar, et al.
Publicado: (2012)

Imatinib Affects the Expression of SLC22A1 in a Non-Linear Concentration-Dependent Manner Within 24 Hours
por: Tantuan, Sandhya Sreenivasan, et al.
Publicado: (2018)

Genetic Heterogeneity of SLC22 Family of Transporters in Drug Disposition
por: Lozano, Elisa, et al.
Publicado: (2018)

Targeting SOS1 overcomes imatinib resistance with BCR-ABL independence through uptake transporter SLC22A4 in CML
por: Liu, Yanjun, et al.
Publicado: (2021)

Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance
por: Heise, Michael, et al.
Publicado: (2012)

AFLP-AFLP in silico-NGS approach reveals polymorphisms in repetitive elements in the malignant genome
por: Koblihova, Jitka, et al.
Publicado: (2018)

Amplicon targeted resequencing for SLC2A9 and SLC22A12 identified novel mutations in hypouricemia subjects
por: Zhou, Zhaowei, et al.
Publicado: (2019)

Active Hydrophilic Components of the Medicinal Herb Salvia miltiorrhiza (Danshen) Potently Inhibit Organic Anion Transporters 1 (Slc22a6) and 3 (Slc22a8)
por: Wang, Li, et al.
Publicado: (2012)

Interactions of 172 plant extracts with human organic anion transporter 1 (SLC22A6) and 3 (SLC22A8): a study on herb-drug interactions
por: Lu, Hang, et al.
Publicado: (2017)

Functional Characterization of Rare Variants in OAT1/SLC22A6 and OAT3/SLC22A8 Urate Transporters Identified in a Gout and Hyperuricemia Cohort
por: Vávra, Jiří, et al.
Publicado: (2022)

Characterization of Exosomal SLC22A5 (OCTN2) carnitine transporter
por: Console, Lara, et al.
Publicado: (2018)

Investigation of the SLC22A23 gene in laryngeal squamous cell carcinoma
por: Ekizoglu, Seda, et al.
Publicado: (2018)

Genetic variants in SLC22A3 contribute to the susceptibility to colorectal cancer
por: Ren, Anjing, et al.
Publicado: (2019)

The influence of metformin transporter gene SLC22A1 and SLC47A1 variants on steady-state pharmacokinetics and glycemic response
por: Ningrum, Vitarani Dwi Ananda, et al.
Publicado: (2022)

Genetic and Epigenetic Regulation of the Organic Cation Transporter 3, SLC22A3
por: Chen, Ligong, et al.
Publicado: (2012)

Introduction of Organic Anion Transporters (SLC22A) and a Regulatory Mechanism by Caveolins
por: Lee, Woon Kyu, et al.
Publicado: (2006)

Interactions of antiretroviral drugs with the SLC22A1 (OCT1) drug transporter
por: Moss, Darren M., et al.
Publicado: (2015)

Polymorphisms of SLC22A9 (hOAT7) in Korean Females with Osteoporosis
por: Ahn, Seong Kyu, et al.
Publicado: (2015)

Phylogenetic, syntenic, and tissue expression analysis of slc22 genes in zebrafish (Danio rerio)
por: Mihaljevic, Ivan, et al.
Publicado: (2016)

Mutations in SLC25A22: hyperprolinaemia, vacuolated fibroblasts and presentation with developmental delay
por: Reid, Emma S., et al.
Publicado: (2017)

Contribution of SLC22A12 on hypouricemia and its clinical significance for screening purposes
por: Cha, Do Hyeon, et al.
Publicado: (2019)

Effect of Cholesterol on the Organic Cation Transporter OCTN1 (SLC22A4)
por: Pochini, Lorena, et al.
Publicado: (2020)

An Iron Metabolism-Related SLC22A17 for the Prognostic Value of Gastric Cancer
por: Wei, Jianming, et al.
Publicado: (2020)

SLC22 Transporters in the Fly Renal System Regulate Response to Oxidative Stress In Vivo
por: Zhang, Patrick, et al.
Publicado: (2021)

Illuminating the Function of the Orphan Transporter, SLC22A10 in Humans and Other Primates
por: Yee, Sook Wah, et al.
Publicado: (2023)

Illuminating the Function of the Orphan Transporter, SLC22A10 in Humans and Other Primates
por: Yee, Sook Wah, et al.
Publicado: (2023)

Organic solute carrier 22 (SLC22) family: Potential for interactions with food, herbal/dietary supplements, endogenous compounds, and drugs
por: Lai, Raymond E., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_igg1orpr409r81drobbdgtsi9b